"Visit the UCLA Health website for coronavirus updates."

During the past decade, UCLA Valencia conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Valencia" #1 collaborator was "Translational Research in Oncology" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Valencia" are "Acinar Cell Adenocarcinoma of the Pancreas" (1 trials), "Duct Cell Adenocarcinoma of the Pancreas" (1 trials), "Early Breast Cancer" (1 trials), "Recurrent Pancreatic Cancer" (1 trials) and "Stage IA Pancreatic Cancer" (1 trials). Many other conditions were trialed in "UCLA Valencia" in a lesser frequency.

Most popular intervention types in "UCLA Valencia" are "Drug" (2 trials), "Other" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Endocrine Therapy" (1 trials), "Ribociclib" (1 trials), "dasatinib" (1 trials), "gemcitabine hydrochloride" (1 trials) and "immunohistochemistry staining method" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Valencia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UCLA Valencia". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UCLA Valencia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Valencia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".